165 related articles for article (PubMed ID: 15718059)
21. Economic benefits of substance abuse treatment: findings from Cuyahoga County, Ohio.
Koenig L; Siegel JM; Harwood H; Gilani J; Chen YJ; Leahy P; Stephens R
J Subst Abuse Treat; 2005; 28 Suppl 1():S41-50. PubMed ID: 15797638
[TBL] [Abstract][Full Text] [Related]
22. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs.
Burdon WM; Dang J; Prendergast ML; Messina NP; Farabee D
Subst Abuse Treat Prev Policy; 2007 May; 2():16. PubMed ID: 17504540
[TBL] [Abstract][Full Text] [Related]
23. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
Chen S; Barnett PG; Sempel JM; Timko C
J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
[TBL] [Abstract][Full Text] [Related]
24. Multidimensional impact of treatment for substance abuse.
Hoffmann NG; Harrison PA; Belille CA
Adv Alcohol Subst Abuse; 1984; 3(3):83-94. PubMed ID: 6496235
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of alcohol and drug treatment programs.
Caldwel JR
J Fla Med Assoc; 1993 Jun; 80(6):385-6. PubMed ID: 8340771
[No Abstract] [Full Text] [Related]
26. Substance use and treatment seeking in young offenders on community orders.
Lennings CJ; Kenny DT; Nelson P
J Subst Abuse Treat; 2006 Dec; 31(4):425-32. PubMed ID: 17084797
[TBL] [Abstract][Full Text] [Related]
27. Incarcerated clients' perceptions of therapeutic change in substance abuse treatment: a 4-year case study.
Smiley-McDonald HM; Leukefeld CG
Int J Offender Ther Comp Criminol; 2005 Oct; 49(5):574-89. PubMed ID: 16260484
[TBL] [Abstract][Full Text] [Related]
28. Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.
Grella CE; Hser YI; Huang YC
Child Abuse Negl; 2006 Jan; 30(1):55-73. PubMed ID: 16406024
[TBL] [Abstract][Full Text] [Related]
29. Impact of role induction on long-term drug treatment outcomes.
Katz EC; Brown BS; Schwartz RP; King SD; Weintraub E; Barksdale W
J Addict Dis; 2007; 26(2):81-90. PubMed ID: 17595001
[TBL] [Abstract][Full Text] [Related]
30. Substance use and psychosocial outcomes following participation in residential laboratory studies of marijuana, methamphetamine and zolpidem.
Vadhan NP; Hart CL; Roe B; Colley J; Haney M; Foltin RW
Am J Drug Alcohol Abuse; 2006; 32(4):589-97. PubMed ID: 17127547
[TBL] [Abstract][Full Text] [Related]
31. Adolescent substance use and hospital presentations: a record linkage assessment of 12-month outcomes.
Tait RJ; Hulse GK
Drug Alcohol Depend; 2005 Sep; 79(3):365-71. PubMed ID: 15896928
[TBL] [Abstract][Full Text] [Related]
32. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
Arévalo S; Prado G; Amaro H
Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
[TBL] [Abstract][Full Text] [Related]
33. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
34. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
[TBL] [Abstract][Full Text] [Related]
35. Client retention in residential drug treatment for Latinos.
Amodeo M; Chassler D; Oettinger C; Labiosa W; Lundgren LM
Eval Program Plann; 2008 Feb; 31(1):102-12. PubMed ID: 18222144
[TBL] [Abstract][Full Text] [Related]
36. Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients.
Joosten EA; de Jong CA; de Weert-van Oene GH; Sensky T; van der Staak CP
Psychother Psychosom; 2009; 78(4):245-53. PubMed ID: 19468259
[TBL] [Abstract][Full Text] [Related]
37. Predictors and outcome of aftercare participation of alcohol and drug users completing residential treatment.
Arbour S; Hambley J; Ho V
Subst Use Misuse; 2011; 46(10):1275-87. PubMed ID: 21615214
[TBL] [Abstract][Full Text] [Related]
38. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
Parthasarathy S; Weisner CM
Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
[TBL] [Abstract][Full Text] [Related]
39. A pilot double-blind treatment trial of memantine for alcohol dependence.
Evans SM; Levin FR; Brooks DJ; Garawi F
Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
[TBL] [Abstract][Full Text] [Related]
40. Predictors of short-term treatment outcomes among California's Proposition 36 participants.
Hser YI; Evans E; Teruya C; Huang D; Anglin MD
Eval Program Plann; 2007 May; 30(2):187-96. PubMed ID: 17689324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
